Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
By A. Cuadrado, A. I. Rojo, G. Wells, J. Hayes, S. P. Cousin, W. Rumsey, Otis C. Attucks, Stephen Franklin, A. Levonen, T. Kensler and 1 more. Nature reviews. Drug discovery, 2019
1,270 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/08f9fc5e9ac0377cffeabeb754afea593c8314d7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- NRF2, a Transcription Factor for Stress Response and Beyond (2020, background): “Imbalance in the generation of ROS is a common feature in several diseases, including neurodegeneration disorders, metabolic disorders, cardiovascular disease, and cancer [80].”